
CAS 2023788-19-2
:Tirzepatide
Description:
Tirzepatide is a novel synthetic peptide that functions as a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is primarily developed for the treatment of type 2 diabetes and obesity. The substance is characterized by its unique structure, which allows it to enhance insulin secretion in response to meals, reduce glucagon levels, and promote satiety, thereby aiding in glycemic control and weight management. Tirzepatide has a long half-life, enabling once-weekly administration, which improves patient compliance compared to daily medications. Its mechanism of action involves mimicking the effects of incretin hormones, leading to improved glucose metabolism. Clinical studies have shown significant efficacy in lowering blood sugar levels and promoting weight loss in individuals with type 2 diabetes. As with any medication, potential side effects may include gastrointestinal issues, and it is essential for patients to consult healthcare professionals for personalized advice and monitoring during treatment.
- Tianeptine Sodium
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Ref: IN-DA01MVDA
1gTo inquire1mg51.00€5mg49.00€10mg70.00€25mg104.00€50mg139.00€100mg165.00€250mg272.00€Tirzepatide
CAS:<p>Tirzepatide (LY-3298176) is a dual glucose-dependent polypeptide (GIP) (EC50=0.042 nM) and glucagon-like peptide-1 (GLP-1) (EC50=0.086 nM) receptor agonist.</p>Formula:C225H348N48O68Purity:99.52% - 99.99%Color and Shape:SolidMolecular weight:4813.45Tirzepatide sodium salt
CAS:Formula:C225H348N48O68·NaxPurity:≥ 95.0%Color and Shape:White to off-white powder or solidMolecular weight:4813.45 (ex. Na)Tirzepatide sodium
CAS:<p>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Formula:C225H348N48O68•xNaPurity:Min. 95 Area-%Color and Shape:PowderHeavy Tirzepatide (+52Da)
CAS:<p>Heavy Tirzepatide (+52Da)</p>Purity:Min. 95%Molecular weight:4,862.7 g/molTirzepatide
CAS:<p>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Formula:C225H348N48O68Purity:Min. 95%Color and Shape:PowderMolecular weight:4,813 g/molTirzepatide acetate
CAS:<p>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Purity:Min. 95%





